{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:26:35Z","timestamp":1793895995124,"version":"4.8.0"},"reference-count":240,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,10]],"date-time":"2027-06-10T00:00:00Z","timestamp":1812585600000},"content-version":"am","delay-in-days":313,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000199","name":"US Department of Agriculture","doi-asserted-by":"publisher","award":["2021-08581"],"award-info":[{"award-number":["2021-08581"]}],"id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jconrel.2026.115070","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:21:54Z","timestamp":1780590114000},"page":"115070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Engineering next-generation nanovaccines for maternal immunization and piglet protection against porcine epidemic diarrhea virus"],"prefix":"10.1016","volume":"396","author":[{"given":"Qiaoqiao","family":"Ci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhi","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Jin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jconrel.2026.115070_bb0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.7774\/cevr.2015.4.2.166","article-title":"Porcine epidemic diarrhea: a review of current epidemiology and available vaccines","volume":"4","author":"Song","year":"2015","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.jconrel.2026.115070_bb0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virusres.2016.05.023","article-title":"Evolution, antigenicity and pathogenicity of global porcine epidemic diarrhea virus strains","volume":"226","author":"Lin","year":"2016","journal-title":"Virus Res."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115070_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194509","article-title":"Survival of viral pathogens in animal feed ingredients under transboundary shipping models","volume":"13","author":"Dee","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.115070_bb0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.virusres.2016.05.016","article-title":"Lactogenic immunity and vaccines for porcine epidemic diarrhea virus (PEDV): historical and current concepts","volume":"226","author":"Langel","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.jconrel.2026.115070_bib1241","doi-asserted-by":"crossref","first-page":"118683","DOI":"10.1016\/j.bios.2026.118683","article-title":"From lab to market: Challenges in translating biosensor innovations to benefit agricultural animal health","volume":"305","author":"Qian","year":"2026","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jconrel.2026.115070_bb0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fmicb.2016.00265","article-title":"Monitoring survivability and infectivity of porcine epidemic diarrhea virus (PEDv) in the infected on-farm earthen manure storages (EMS)","volume":"7","author":"Tun","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115070_bb0030","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fvets.2020.00433","article-title":"Evaluating the risk factors for porcine epidemic diarrhea virus infection in an endemic area of Vietnam","volume":"7","author":"Mai","year":"2020","journal-title":"Front. Vet. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115070_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158128","article-title":"Comparison of thermal and non-thermal processing of swine feed and the use of selected feed additives on inactivation of porcine epidemic diarrhea virus (PEDV)","volume":"11","author":"Trudeau","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.115070_bb0040","article-title":"Evaluation of porcine epidemic diarrhea virus RNA contamination on swine industry transportation vehicles","volume":"237","author":"Parker","year":"2025","journal-title":"Prevent. Veterin. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13567-014-0073-z","article-title":"Evidence of infectivity of airborne porcine epidemic diarrhea virus and detection of airborne viral RNA at long distances from infected herds","volume":"45","author":"Alonso","year":"2014","journal-title":"Vet. Res."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115070_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135675","article-title":"Concentration, size distribution, and infectivity of airborne particles carrying swine viruses","volume":"10","author":"Alonso","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.115070_bb0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.virusres.2016.08.005","article-title":"Status of vaccines for porcine epidemic diarrhea virus in the United States and Canada","volume":"226","author":"Crawford","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.jconrel.2026.115070_bb0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vetmic.2016.11.029","article-title":"Vaccines for porcine epidemic diarrhea virus and other swine coronaviruses","volume":"206","author":"Gerdts","year":"2016","journal-title":"Vet. Microbiol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115070_bb0065","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s11250-020-02270-1","article-title":"Field trials evaluating the efficacy of porcine epidemic diarrhea vaccine, RNA (Harrisvaccine) in the Philippines","volume":"52","author":"Sawattrakool","year":"2020","journal-title":"Trop. Anim. Health Prod."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0070","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.rvsc.2006.03.007","article-title":"Oral efficacy of Vero cell attenuated porcine epidemic diarrhea virus DR13 strain","volume":"82","author":"Song","year":"2007","journal-title":"Res. Vet. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12985-015-0421-2","article-title":"Porcine epidemic diarrhea virus: an emerging and re-emerging epizootic swine virus","volume":"12","author":"Lee","year":"2015","journal-title":"Virol. J."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115070_bb0080","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3390\/vaccines8040642","article-title":"Efficacy of porcine epidemic diarrhea vaccines: a systematic review and meta-analysis","volume":"8","author":"Won","year":"2020","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11262-011-0617-5","article-title":"Mutations in the spike gene of porcine epidemic diarrhea virus associated with growth adaptation in vitro and attenuation of virulence in vivo","volume":"43","author":"Sato","year":"2011","journal-title":"Virus Genes"},{"issue":"null","key":"10.1016\/j.jconrel.2026.115070_bb0090","first-page":"1","article-title":"Porcine epidemic diarrhea virus: current insights","volume":"8","author":"Lv","year":"2016","journal-title":"Virus Adapt. Treat."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115070_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/v14081801","article-title":"Evaluation of the efficacy of an S-INDEL PEDV strain administered to pregnant gilts against a virulent Non-S-INDEL PEDV challenge in newborn piglets","volume":"14","author":"Schumacher","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2026.115070_bb0100","series-title":"James D. McKeanSwine Disease Conference Proceedings","article-title":"Evaluation of the effects of PEDv vaccine on PEDv na\u00efve and previously PEDv-exposed sows in a challenge model comparing immune response and preweaning mortality","author":"Schwartz","year":"2015"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41541-025-01195-w","article-title":"Safety and efficacy of live attenuated PEDV vaccines for neonatal protection","volume":"10","author":"Li","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2026.115070_bb0110","article-title":"The new porcine epidemic diarrhea virus outbreak may mean that existing commercial vaccines are not enough to fully protect against the epidemic strains","volume":"8","author":"Gao","year":"2021","journal-title":"Front. Veterin. Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115070_bb0115","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3201\/eid1803.120002","article-title":"New variants of porcine epidemic diarrhea virus, China, 2011","volume":"18","author":"Li","year":"2012","journal-title":"Emerg. Infect. Dis."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115070_bb0120","doi-asserted-by":"crossref","DOI":"10.4142\/jvs.23090","article-title":"Porcine epidemic diarrhea virus: an update overview of virus epidemiology, vaccines, and control strategies in South Korea","volume":"24","author":"Jang","year":"2023","journal-title":"J. Vet. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115070_bb0125","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00705-015-2694-6","article-title":"Immunogenicity and antigenic relationships among spike proteins of porcine epidemic diarrhea virus subtypes G1 and G2","volume":"161","author":"Wang","year":"2016","journal-title":"Arch. Virol."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115070_bb0130","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.2460\/javma.2020.257.11.1142","article-title":"Review of updated regulations and product license categories for veterinary vaccines in the United States","volume":"257","author":"Erdman","year":"2020","journal-title":"J. Am. Vet. Med. Assoc."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115070_bb0135","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01309-24","article-title":"Efficacy evaluation of a bivalent subunit vaccine against epidemic PEDV heterologous strains with low cross-protection","volume":"98","author":"Song","year":"2024","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-62875-6","article-title":"Evolution and virulence of porcine epidemic diarrhea virus following in vitro and in vivo propagation","volume":"14","author":"Jermsutjarit","year":"2024","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115070_bb0145","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41565-022-01129-w","article-title":"Characterization of nanoparticles-based vaccines for COVID-19","volume":"17","author":"Guerrini","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115070_bb0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-bioeng-110122-124359","article-title":"Next-generation vaccine development with nanomaterials: recent advances, possibilities, and challenges","volume":"26","author":"Shetty","year":"2024","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115070_bb0155","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jconrel.2017.04.024","article-title":"Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses","volume":"256","author":"Kang","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115070_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133008","article-title":"Mucoadhesive chitosan-catechol as an efficient vaccine delivery system for intranasal immunization","volume":"273","author":"Deng","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115070_bb0165","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3390\/ani13050889","article-title":"The oral inactivated porcine epidemic diarrhea virus presenting in the intestine induces mucosal immunity in mice with Alginate\u2013Chitosan microcapsules","volume":"13","author":"Qin","year":"2023","journal-title":"Animals"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115070_bb0170","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.immuni.2023.08.011","article-title":"Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses","volume":"56","author":"Ols","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115070_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2024.110003","article-title":"Enhancing humoral and mucosal immune response of PED vaccine candidate by fusing S1 protein to nanoparticle multimerization","volume":"290","author":"Li","year":"2024","journal-title":"Vet. Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0180","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/s41467-024-44869-0","article-title":"Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds","volume":"15","author":"Wamhoff","year":"2024","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.jconrel.2026.115070_bb0185","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.vaccine.2014.02.027","article-title":"Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release","volume":"32","author":"Ilyinskii","year":"2014","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115070_bb0190","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115070_bb0195","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.1021\/acsnano.8b02805","article-title":"Engineering a rugged nanoscaffold to enhance plug-and-display vaccination","volume":"12","author":"Bruun","year":"2018","journal-title":"ACS Nano"},{"issue":"19","key":"10.1016\/j.jconrel.2026.115070_bb0200","doi-asserted-by":"crossref","first-page":"12235","DOI":"10.1021\/acsnano.4c00809","article-title":"Combination of S1\u2013N\u2013terminal and S1\u2013C\u2013terminal domain antigens targeting double receptor-binding domains bolsters protective immunity of a nanoparticle vaccine against porcine epidemic diarrhea virus","volume":"18","author":"Yang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115070_bb0235","article-title":"Bivalent circular RNA vaccines against porcine epidemic diarrhea virus and transmissible gastroenteritis virus","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115070_bb0240","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02958-23","article-title":"PEDV-spike-protein-expressing mRNA vaccine protects piglets against PEDV challenge","volume":"15","author":"Zhao","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.jconrel.2026.115070_bb0245","doi-asserted-by":"crossref","DOI":"10.1155\/tbed\/6727844","article-title":"Prevention of Porcine Epidemic Diarrhea Virus With Nanotube-Adjuvanted Oral DNA Vaccines","volume":"2026","author":"Wu","year":"2026","journal-title":"Transbound. Emerg. Dis."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115070_bb0250","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00273-17","article-title":"Cell attachment domains of the porcine epidemic diarrhea virus spike protein are key targets of neutralizing antibodies","volume":"91","author":"Li","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2026.115070_bb0255","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12985-016-0512-8","article-title":"S1 domain of the porcine epidemic diarrhea virus spike protein as a vaccine antigen","volume":"13","author":"Makadiya","year":"2016","journal-title":"Virol. J."},{"key":"10.1016\/j.jconrel.2026.115070_bb0260","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coviro.2016.03.001","article-title":"Engineering virus-like particles as vaccine platforms","volume":"18","author":"Frietze","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jconrel.2026.115070_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2025.110412","article-title":"Toward developing multistrain PEDV vaccines: Integrating basic concepts and SARS-CoV-2 pan-sarbecovirus strategies","volume":"604","author":"Fragoso-Saavedra","year":"2025","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115070_bb0265","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.vaccine.2018.01.086","article-title":"PED subunit vaccine based on COE domain replacement of flagellin domain D3 improved specific humoral and mucosal immunity in mice","volume":"36","author":"Li","year":"2018","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115070_bb0270","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20182028","article-title":"Mucosal immune responses induced by oral administration recombinant Bacillus subtilis expressing the COE antigen of PEDV in newborn piglets","volume":"39","author":"Wang","year":"2019","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/v14010007","article-title":"Immune responses in pregnant sows induced by recombinant Lactobacillus johnsonii expressing the COE protein of porcine epidemic diarrhea virus provide protection for piglets against PEDV infection","volume":"14","author":"Zheng","year":"2021","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115070_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/v9110312","article-title":"Oral delivery of probiotics expressing dendritic cell-targeting peptide fused with porcine epidemic diarrhea virus COE antigen: a promising vaccine strategy against PEDV","volume":"9","author":"Wang","year":"2017","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115070_bb0285","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00692-24","article-title":"Intranasal delivery of a recombinant adenovirus vaccine encoding the PEDV COE elicits potent mucosal and systemic antibody responses in mice","volume":"12","author":"Yan","year":"2024","journal-title":"Microbiol. Spectrum"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115070_bb0290","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1016\/j.jia.2024.05.002","article-title":"Plug-and-display nanoparticle immunization of the core epitope domain induces potent neutralizing antibody and cellular immune responses against PEDV","volume":"24","author":"Li","year":"2025","journal-title":"J. Integr. Agric. (JIA)"},{"key":"10.1016\/j.jconrel.2026.115070_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.02152","article-title":"Plant-derived trimeric CO-26\u00a0K-equivalent epitope induced neutralizing antibodies against porcine epidemic diarrhea virus","volume":"11","author":"Ho","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0300","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13567-025-01542-8","article-title":"Ferritin-based nanoparticle vaccine protects neonatal piglets against porcine epidemic diarrhea virus challenge following immunization of pregnant sows","volume":"56","author":"Liu","year":"2025","journal-title":"Vet. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115070_bb0305","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11051-025-06351-w","article-title":"The effect of silica nanoparticles on the immunogenicity of plant-based recombinant COE protein of porcine epidemic diarrhea virus in mice","volume":"27","author":"Ho","year":"2025","journal-title":"J. Nanopart. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115070_bb0310","doi-asserted-by":"crossref","DOI":"10.4110\/in.2018.18.e21","article-title":"N-terminal domain of the spike protein of porcine epidemic diarrhea virus as a new candidate molecule for a mucosal vaccine","volume":"18","author":"Kim","year":"2018","journal-title":"Immune Netw."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115070_bb0315","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/v16030431","article-title":"Development of glycyrrhizinic acid-based lipid nanoparticle (LNP-GA) as an adjuvant that improves the immune response to porcine epidemic diarrhea virus spike recombinant protein","volume":"16","author":"Garc\u00eda-Cambr\u00f3n","year":"2024","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0320","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13567-025-01559-z","article-title":"A bacteriophage-based virus-like particle vaccine induces cross-reactive neutralizing antibodies against porcine epidemic diarrhea viruses (PEDV)","volume":"56","author":"Gu","year":"2025","journal-title":"Vet. Res."},{"issue":"23","key":"10.1016\/j.jconrel.2026.115070_bb0325","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00923-19","article-title":"The 3.1-angstrom cryo-electron microscopy structure of the porcine epidemic diarrhea virus spike protein in the prefusion conformation","volume":"93","author":"Wrapp","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2026.115070_bb0330","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jviromet.2017.11.003","article-title":"Hepatitis B core antigen based novel vaccine against porcine epidemic diarrhea virus","volume":"253","author":"Gillam","year":"2018","journal-title":"J. Virol. Methods"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0335","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1038\/s41467-022-32588-3","article-title":"In situ structure and dynamics of an alphacoronavirus spike protein by cryo-ET and cryo-EM","volume":"13","author":"Huang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115070_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1269409","article-title":"Intranasally inoculated bacterium-like particles displaying porcine epidemic diarrhea virus S1 protein induced intestinal mucosal immune response in mice","volume":"14","author":"Su","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115070_bb0345","article-title":"Spike 1 trimer, a nanoparticle vaccine against porcine epidemic diarrhea virus induces protective immunity challenge in piglets","volume":"15","author":"Li","year":"2024","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0350","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1038\/s41598-019-39844-5","article-title":"Identification of neutralizing monoclonal antibodies targeting novel conformational epitopes of the porcine epidemic diarrhea virus spike protein","volume":"9","author":"Chang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115070_bb0355","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.virol.2017.06.013","article-title":"The S2 glycoprotein subunit of porcine epidemic diarrhea virus contains immunodominant neutralizing epitopes","volume":"509","author":"Okda","year":"2017","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115070_bb0360","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1128\/JVI.00430-15","article-title":"Receptor usage and cell entry of porcine epidemic diarrhea coronavirus","volume":"89","author":"Liu","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2026.115070_bb0365","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.virusres.2016.05.031","article-title":"Cellular entry of the porcine epidemic diarrhea virus","volume":"226","author":"Li","year":"2016","journal-title":"Virus Res."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115070_bb0370","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/v8030055","article-title":"Identification and comparison of receptor binding characteristics of the spike protein of two porcine epidemic diarrhea virus strains","volume":"8","author":"Deng","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2026.115070_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1674222","article-title":"A nanodiamond-formulated plant protein induces robust immunity against porcine epidemic diarrhea virus in piglets","volume":"16","author":"Ho","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115070_bb0380","first-page":"0761","article-title":"Nanomaterial adjuvants for veterinary vaccines: mechanisms and applications","volume":"8","author":"He","year":"2025","journal-title":"Research (Wash D C)"},{"key":"10.1016\/j.jconrel.2026.115070_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2020.01.007","article-title":"Shaping humoral immunity to vaccines through antigen-displaying nanoparticles","volume":"65","author":"Irvine","year":"2020","journal-title":"Curr. Opin. Immunol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115070_bb0390","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.3390\/ijms24076183","article-title":"Effective multivalent oriented presentation of meningococcal NadA antigen trimers by self-assembling ferritin nanoparticles","volume":"24","author":"Veggi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"30","key":"10.1016\/j.jconrel.2026.115070_bb0395","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1016\/j.vaccine.2018.06.015","article-title":"Epitope selection and their placement for increased virus neutralization in a novel vaccination strategy for porcine epidemic diarrhea virus utilizing the Hepatitis B virus core antigen","volume":"36","author":"Gillam","year":"2018","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.jconrel.2026.115070_bb0400","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1016\/j.vaccine.2020.06.009","article-title":"Virus-like particle vaccine with B-cell epitope from porcine epidemic diarrhea virus (PEDV) incorporated into hepatitis B virus core capsid provides clinical alleviation against PEDV in neonatal piglets through lactogenic immunity","volume":"38","author":"Lu","year":"2020","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115070_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/v14071371","article-title":"Antigenicity alternations of variant PEDV s protein disclosed by linear B cell epitope mapping","volume":"14","author":"Yu","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2026.115070_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2020.108955","article-title":"A porcine epidemic diarrhea virus strain with distinct characteristics of four amino acid insertion in the COE region of spike protein","volume":"253","author":"Ji","year":"2021","journal-title":"Vet. Microbiol."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115070_bb0415","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf1591","article-title":"Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates","volume":"7","author":"He","year":"2021","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115070_bb0420","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3390\/vaccines9060539","article-title":"Head-to-head comparison of modular vaccines developed using different capsid virus-like particle backbones and antigen conjugation systems","volume":"9","author":"Fredsgaard","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2026.115070_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1396894","article-title":"Research progress of porcine epidemic diarrhea virus S protein","volume":"15","author":"Luo","year":"2024","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115070_bb0430","article-title":"Porcine epidemic diarrhea: insights and progress on vaccines","volume":"12","author":"Park","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115070_bb0435","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41423-020-0374-2","article-title":"Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein","volume":"17","author":"Xia","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115070_bb0440","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1128\/JVI.02287-07","article-title":"Coronavirus escape from heptad repeat 2 (HR2)-derived peptide entry inhibition as a result of mutations in the HR1 domain of the spike fusion protein","volume":"82","author":"Bosch","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2026.115070_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.11.021","article-title":"Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies","volume":"150","author":"Zhao","year":"2018","journal-title":"Antivir. Res."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115070_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/v14081744","article-title":"PEDV: insights and advances into types, function, structure, and receptor recognition","volume":"14","author":"Lin","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2026.115070_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110113","article-title":"Construction and immune effect evaluation of the S protein heptad repeat-based nanoparticle vaccine against porcine epidemic diarrhea virus","volume":"596","author":"Yang","year":"2024","journal-title":"Virology"},{"issue":"655","key":"10.1016\/j.jconrel.2026.115070_bb0460","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn3715","article-title":"SARS-CoV-2\u00a0S2-targeted vaccination elicits broadly neutralizing antibodies","volume":"14","author":"Ng","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115070_bb0465","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2023.02.005","article-title":"Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease","volume":"56","author":"Zhou","year":"2023","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115070_bb0470","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41577-022-00784-3","article-title":"Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses","volume":"23","author":"Chen","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115070_bb0475","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41422-022-00746-3","article-title":"A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein","volume":"32","author":"Pang","year":"2022","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115070_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41565-020-0739-9","article-title":"Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health","volume":"16","author":"Fries","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115070_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113914","article-title":"Vaccine delivery systems toward lymph nodes","volume":"179","author":"Ding","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115070_bb0490","doi-asserted-by":"crossref","DOI":"10.3390\/v12101122","article-title":"Parenterally administered porcine epidemic diarrhea virus-like particle-based vaccine formulated with CCL25\/28 chemokines induces systemic and mucosal immune protectivity in pigs","volume":"12","author":"Hsu","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2026.115070_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2025.110451","article-title":"Constructions and immunogenicity evaluations of two porcine epdemic diarrhea virus-like particle vaccines","volume":"303","author":"Xu","year":"2025","journal-title":"Vet. Microbiol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115070_bb0500","article-title":"Construction of porcine epidemic diarrhea virus-like particles and its immunogenicity in mice","volume":"9","author":"Kim","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2026.115070_bb0505","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1251001","article-title":"Virus-like particle vaccines with epitopes from porcine epidemic virus and transmissible gastroenteritis virus incorporated into self-assembling ADDomer platform provide clinical immune responses in piglets","volume":"14","author":"Du","year":"2023","journal-title":"Front. Immunol."},{"issue":"50","key":"10.1016\/j.jconrel.2026.115070_bb0510","doi-asserted-by":"crossref","first-page":"7010","DOI":"10.1016\/j.vaccine.2017.10.054","article-title":"Poly (d,l-lactide-co-glycolide) nanoparticle-entrapped vaccine induces a protective immune response against porcine epidemic diarrhea virus infection in piglets","volume":"35","author":"Li","year":"2017","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115070_bb0515","article-title":"Immune enhancement of nanoparticle-encapsulated ginseng stem-leaf saponins on porcine epidemic diarrhea virus vaccine in mice","volume":"10","author":"Su","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0520","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13567-025-01695-6","article-title":"Intestinal mucosal immune responses induced by oral administration of chitosan nanoparticles encapsulating the PEDV S1 protein","volume":"57","author":"Su","year":"2025","journal-title":"Vet. Res."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115070_bb0525","article-title":"Oral delivery of Lactococcus lactis expressing full-length s protein via alginate-chitosan capsules induces immune protection against PEDV infection in mice","volume":"13","author":"Yang","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2026.115070_bb0530","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2147\/IJN.S496077","article-title":"N-2-hydroxypropyl trimethyl ammonium chloride chitosan-aluminum nano-adjuvant elicit strong immune responses in porcine epidemic diarrhea inactivated vaccine","volume":"20","author":"Jin","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115070_bb0535","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.virol.2021.10.010","article-title":"LDH nanoparticle adjuvant subunit vaccine induces an effective immune response for porcine epidemic diarrhea virus","volume":"565","author":"Shi","year":"2022","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2026.115070_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.141345","article-title":"Enhanced mucosal immune response through nanoparticle delivery system based on chitosan-catechol and a recombinant antigen targeted toward M cells","volume":"306","author":"Wan","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115070_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/cells15020208","article-title":"Development of a cellular membrane nanovesicle-based vaccine against porcine epidemic diarrhea virus","volume":"15","author":"Wang","year":"2026","journal-title":"Cells"},{"issue":"15","key":"10.1016\/j.jconrel.2026.115070_bb0550","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157047","article-title":"Ferritin nanocages exhibit unique structural dynamics when displaying surface protein","volume":"26","author":"Padariya","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.jconrel.2026.115070_bb0555","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29174221","article-title":"Self-assembled ferritin nanoparticles for delivery of antigens and development of vaccines: from structure and property to applications","volume":"29","author":"Cao","year":"2024","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0560","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1038\/s41467-024-52908-z","article-title":"Self-assembling nanoparticle engineered from the ferritinophagy complex as a rabies virus vaccine candidate","volume":"15","author":"Fu","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115070_bb0565","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41591-021-01660-8","article-title":"Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial","volume":"28","author":"Houser","year":"2022","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0570","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12951-021-00806-7","article-title":"Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers","volume":"19","author":"Nooraei","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115070_bb0575","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.1021\/acs.nanolett.9b02834","article-title":"Nanoparticle size influences antigen retention and presentation in lymph node follicles for humoral immunity","volume":"19","author":"Zhang","year":"2019","journal-title":"Nano Lett."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115070_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113552","article-title":"Antigen spacing on protein nanoparticles influences antibody responses to vaccination","volume":"42","author":"Ellis","year":"2023","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115070_bb0585","doi-asserted-by":"crossref","DOI":"10.3390\/v12020185","article-title":"Advantages and prospects of tag\/catcher mediated antigen display on capsid-like particle-based vaccines","volume":"12","author":"Aves","year":"2020","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0590","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41541-021-00391-8","article-title":"Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines","volume":"6","author":"Sartorius","year":"2021","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.jconrel.2026.115070_bb0595","article-title":"TLR7 signaling shapes and maintains antibody diversity upon virus-like particle immunization","volume":"12","author":"Chang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115070_bb0600","doi-asserted-by":"crossref","first-page":"19234","DOI":"10.1038\/srep19234","article-title":"Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization","volume":"6","author":"Brune","year":"2016","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115070_bb0605","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.1073\/pnas.1115485109","article-title":"Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin","volume":"109","author":"Zakeri","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"52","key":"10.1016\/j.jconrel.2026.115070_bb0610","doi-asserted-by":"crossref","first-page":"16521","DOI":"10.1002\/anie.201707623","article-title":"Evolving accelerated amidation by SpyTag\/SpyCatcher to analyze membrane dynamics","volume":"56","author":"Keeble","year":"2017","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"52","key":"10.1016\/j.jconrel.2026.115070_bb0615","doi-asserted-by":"crossref","first-page":"26523","DOI":"10.1073\/pnas.1909653116","article-title":"Approaching infinite affinity through engineering of peptide\u2013protein interaction","volume":"116","author":"Keeble","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115070_bb0620","doi-asserted-by":"crossref","DOI":"10.3390\/v16060936","article-title":"Protein nanoparticles as vaccine platforms for human and zoonotic viruses","volume":"16","author":"Pandey","year":"2024","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115070_bb0625","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1073\/pnas.1519214113","article-title":"Programmable polyproteams built using twin peptide superglues","volume":"113","author":"Veggiani","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115070_bb0630","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1021\/acs.bioconjchem.7b00174","article-title":"Dual plug-and-display synthetic assembly using orthogonal reactive proteins for twin antigen immunization","volume":"28","author":"Brune","year":"2017","journal-title":"Bioconjug. Chem."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115070_bb0635","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.chembiol.2021.07.005","article-title":"DogCatcher allows loop-friendly protein-protein ligation","volume":"29","author":"Keeble","year":"2022","journal-title":"Cell Chem. Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0640","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/s41467-019-09678-w","article-title":"Spy&Go purification of SpyTag-proteins using pseudo-SpyCatcher to access an oligomerization toolbox","volume":"10","author":"Khairil Anuar","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115070_bb0230","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijbiomac.2022.12.006","article-title":"Spy&IAC enables specific capture of SpyTagged proteins for rapid assembly of plug-and-display nanoparticle vaccines","volume":"226","author":"Chen","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115070_bb0645","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers (Basel)"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115070_bb0650","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122728","article-title":"PLGA-based nanomedicine: history of advancement and development in clinical applications of multiple diseases","volume":"14","author":"Alsaab","year":"2022","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115070_bb0655","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/10915818251355948","article-title":"Safety and toxicological evaluation of subunit keyhole limpet hemocyanin-loaded lipid\u2013PLGA hybrid nanoparticles (sKLH-hNPs) as a nanocarrier for an opioid use disorder vaccine","volume":"44","author":"Walter","year":"2025","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.jconrel.2026.115070_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114294","article-title":"Innate immune mechanisms underlying the efficacy of a next-generation nanoparticle-based vaccine against opioid use disorders","volume":"388","author":"Hamid","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115070_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122758","article-title":"The immunological and pharmacokinetic evaluation of Lipid-PLGA hybrid nanoparticle-based oxycodone vaccines","volume":"313","author":"Walter","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115070_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123776","article-title":"IFN-\u03b3 and TLR agonist co-adjuvants enhance the efficacy of a lipid-PLGA hybrid nanoparticle-based oxycodone vaccine","volume":"327","author":"Bian","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115070_bb0675","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3389\/fimmu.2017.01077","article-title":"Co-delivery of dual toll-like receptor agonists and antigen in poly(Lactic-Co-Glycolic) Acid\/polyethylenimine cationic hybrid nanoparticles promote efficient in vivo immune responses","volume":"8","author":"Ebrahimian","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115070_bb0685","series-title":"Nanoengineered Biomaterials for Advanced Drug Delivery","first-page":"603","article-title":"25 - nanoparticles for mucosal vaccine delivery","author":"Thakur","year":"2020"},{"key":"10.1016\/j.jconrel.2026.115070_bb0690","article-title":"Nanotechnology-driven advances in intranasal vaccine delivery systems against infectious diseases","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115070_bb0695","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00934","article-title":"Mucosal immunity and protective efficacy of intranasal inactivated influenza vaccine is improved by chitosan nanoparticle delivery in pigs","volume":"9","author":"Dhakal","year":"2018","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.jconrel.2026.115070_bb0700","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158044","article-title":"Review of dendritic cells, their role in clinical immunology, and distribution in various animal species","volume":"22","author":"Zanna","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115070_bb0705","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70455","article-title":"Dendritic cells: origin, classification, development, biological functions, and therapeutic potential","volume":"6","author":"Jin","year":"2020","journal-title":"MedComm"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115070_bb0710","doi-asserted-by":"crossref","DOI":"10.3390\/v15051198","article-title":"Efficiency of interferon-\u03b3 in activating dendritic cells and its potential synergy with toll-like receptor agonists","volume":"15","author":"Bian","year":"2023","journal-title":"Viruses"},{"issue":"19","key":"10.1016\/j.jconrel.2026.115070_bb0715","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1016\/j.biomaterials.2012.03.041","article-title":"Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype","volume":"33","author":"Demento","year":"2012","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115070_bb0720","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/21645515.2015.1117714","article-title":"PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity","volume":"12","author":"Silva","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2026.115070_bb0725","series-title":"Mucosal Vaccines","first-page":"325","article-title":"Chapter 19 - current and new approaches for mucosal vaccine delivery","author":"Rhee","year":"2020"},{"issue":"44","key":"10.1016\/j.jconrel.2026.115070_bb0730","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1016\/j.vaccine.2015.07.101","article-title":"Chitosan-based mucosal adjuvants: Sunrise on the ocean","volume":"33","author":"Xia","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0735","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2010.08.020","article-title":"Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution","volume":"400","author":"Vllasaliu","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"19","key":"10.1016\/j.jconrel.2026.115070_bb0740","doi-asserted-by":"crossref","DOI":"10.3390\/polym13193317","article-title":"Mussel-inspired catechol functionalisation as a strategy to enhance biomaterial adhesion: a systematic review","volume":"13","author":"Costa","year":"2021","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jconrel.2026.115070_bb0745","first-page":"39","article-title":"M cell-targeted mucosal vaccine strategies","volume":"354","author":"Yamamoto","year":"2012","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0750","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jaci.2015.07.042","article-title":"Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity","volume":"137","author":"Rochereau","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115070_bb0755","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.apsb.2020.02.011","article-title":"The construction of in vitro nasal cavity-mimic M-cell model, design of M cell-targeting nanoparticles and evaluation of mucosal vaccination by nasal administration","volume":"10","author":"Yang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115070_bb0760","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0169-409X(01)00197-1","article-title":"Chitosan for mucosal vaccination","volume":"52","author":"van der Lubben","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115070_bb0775","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/vaccines11030661","article-title":"Emerging trends in lipid-based vaccine delivery: a special focus on developmental strategies, fabrication methods, and applications","volume":"11","author":"Karunakaran","year":"2023","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115070_bb0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101463","article-title":"Lipid nanoparticles: composition, formulation, and application","volume":"33","author":"Xu","year":"2025","journal-title":"Mol. Therapy Methods Clin. Develop."},{"issue":"19","key":"10.1016\/j.jconrel.2026.115070_bb0785","first-page":"3841","article-title":"[Effects of glycyrrhizin acid and licorice flavonoids on LPS-induced cytokines expression in macrophage]. Zhongguo Zhong yao za zhi\u00a0=\u00a0Zhongguo zhongyao zazhi\u00a0=","volume":"39","author":"Liu","year":"2014","journal-title":"China J. Chin. Mater. Med."},{"key":"10.1016\/j.jconrel.2026.115070_bb0790","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4569521","article-title":"Inhibiting HMGB1 with glycyrrhizic acid protects brain injury after DAI via its anti-inflammatory effect","volume":"2016","author":"Pang","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115070_bb0795","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3390\/v17091210","article-title":"Development of a safe and effective mRNA candidate vaccine against PEDV G2c genotype infection","volume":"17","author":"Zhu","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2026.115070_bb0800","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nantod.2019.04.005","article-title":"Designing inorganic nanomaterials for vaccines and immunotherapies","volume":"27","author":"Hess","year":"2019","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115070_bb0805","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02224","article-title":"Nanoparticle vaccines against infectious diseases","volume":"9","author":"Pati","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115070_bb0810","first-page":"11","article-title":"Nanoparticle-based delivery systems for vaccines","volume":"10","author":"Bezbaruah","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115070_bb0815","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/vaccines11071172","article-title":"Nanoparticle-based adjuvants and delivery systems for modern vaccines","volume":"11","author":"Filipi\u0107","year":"2023","journal-title":"Vaccines"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115070_bb0820","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3390\/vaccines10091549","article-title":"Nanoclays: promising materials for vaccinology","volume":"10","author":"Govea-Alonso","year":"2022","journal-title":"Vaccines"},{"issue":"15","key":"10.1016\/j.jconrel.2026.115070_bb0825","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.3390\/ma16155467","article-title":"Assessing the adjuvant effect of layered double hydroxides (LDH) on BALB\/c mice","volume":"16","author":"Govea-Alonso","year":"2023","journal-title":"Materials"},{"key":"10.1016\/j.jconrel.2026.115070_bb0830","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3389\/fphar.2018.01060","article-title":"The pathways for layered double hydroxide nanoparticles to enhance antigen (Cross)-presentation on immune cells as adjuvants for protein vaccines","volume":"9","author":"Yan","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115070_bb0840","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1039\/c3nr00357d","article-title":"Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery","volume":"5","author":"Mody","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.115070_bb0850","first-page":"5(4)","article-title":"Exposure to inorganic nanoparticles: routes of entry, immune response, biodistribution and in vitro\/in vivo toxicity evaluation","author":"De Matteis","year":"2017","journal-title":"Toxics"},{"key":"10.1016\/j.jconrel.2026.115070_bb0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.105979","article-title":"Pharmacokinetics and toxicity of inorganic nanoparticles and the physicochemical properties\/factors affecting them","volume":"99","author":"Saker","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115070_bb0860","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1021\/acsnano.9b01383","article-title":"Elimination pathways of nanoparticles","volume":"13","author":"Poon","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115070_bb0865","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle\u2013liver interactions: cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0870","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1038\/s41467-018-06730-z","article-title":"Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics","volume":"9","author":"Dogra","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115070_bb0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115049","article-title":"Biosafety of mesoporous silica nanoparticles; toward clinical translation","volume":"201","author":"L\u00e9rida-Viso","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5547","key":"10.1016\/j.jconrel.2026.115070_bb0880","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.1063187","article-title":"Self-assembly and mineralization of peptide-Amphiphile Nanofibers","volume":"294","author":"Hartgerink","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115070_bb0885","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.actbio.2021.05.003","article-title":"Peptide-based supramolecular vaccine systems","volume":"133","author":"O'Neill","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.115070_bb0890","article-title":"Supramolecular self-assembled peptide-based vaccines: current state and future perspectives. frontiers","volume":"8","author":"Abdullah","year":"2020","journal-title":"Chemistry"},{"issue":"104","key":"10.1016\/j.jconrel.2026.115070_bb0895","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ado5937","article-title":"Linking vaccine adjuvant mechanisms of action to function","volume":"10","author":"Ben-Akiva","year":"2025","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0900","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115070_bb0905","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115070_bb0910","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3390\/pharmaceutics17091223","article-title":"precision adjuvant strategies in vaccine development for substance use disorders: variability and mechanistic insights","volume":"17","author":"Bian","year":"2025","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115070_bb0915","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115070_bb0920","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI81083","article-title":"Beyond antigens and adjuvants: formulating future vaccines","volume":"126","author":"Moyer","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.115070_bb0925","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.addr.2020.06.019","article-title":"Controlling timing and location in vaccines","volume":"158","author":"Irvine","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115070_bb0930","article-title":"A novel CpG ODN compound adjuvant enhances immune response to spike subunit vaccines of porcine epidemic diarrhea virus","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115070_bb0935","doi-asserted-by":"crossref","DOI":"10.3390\/v14112434","article-title":"Porcine epidemic diarrhea virus: an updated overview of virus epidemiology, virulence variation patterns and virus-host interactions","volume":"14","author":"Zhang","year":"2022","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115070_bb0940","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071701","article-title":"RNA recognition and immunity-innate immune sensing and its posttranscriptional regulation mechanisms","volume":"9","author":"Uehata","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115070_bb0945","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/cmi.2012.38","article-title":"TLR8: the forgotten relative revindicated","volume":"9","author":"Cervantes","year":"2012","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115070_bb0950","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/eji.201344127","article-title":"Recognition of cytosolic DNA by cGAS and other STING-dependent sensors","volume":"44","author":"Bhat","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115070_bb0955","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4049\/immunohorizons.1700063","article-title":"Recent advances in the discovery and delivery of TLR7\/8 agonists as vaccine adjuvants","volume":"2","author":"Dowling","year":"2018","journal-title":"ImmunoHorizons"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115070_bb0960","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1172\/JCI31414","article-title":"Development of TLR9 agonists for cancer therapy","volume":"117","author":"Krieg","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb0965","article-title":"Anti-IgE Qb-VLP conjugate vaccine self-adjuvants through activation of TLR7","volume":"4","author":"Akache","year":"2016","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115070_bb0970","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/vaccines9040403","article-title":"AP205 VLPs based on dimerized capsid proteins accommodate RBM domain of SARS-CoV-2 and serve as an attractive vaccine candidate","volume":"9","author":"Liu","year":"2021","journal-title":"Vaccines"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115070_bb0975","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","article-title":"CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity","volume":"186","author":"Chu","year":"1997","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115070_bb0980","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1586\/14760584.2014.863715","article-title":"Recent progress concerning CpG DNA and its use as a vaccine adjuvant","volume":"13","author":"Shirota","year":"2014","journal-title":"Expert Rev. Vaccines"},{"issue":"48","key":"10.1016\/j.jconrel.2026.115070_bb0985","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1016\/j.vaccine.2014.06.065","article-title":"Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer","volume":"32","author":"Scheiermann","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115070_bb0990","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1631\/jzus.2007.B0153","article-title":"Adjuvant effects of saponins on animal immune responses","volume":"8","author":"Rajput","year":"2007","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.jconrel.2026.115070_bb0995","article-title":"Potentials of saponins-based adjuvants for nasal vaccines","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115070_bb1000","article-title":"QS-21: A Potent Vaccine Adjuvant","volume":"3","author":"Zhu","year":"2016","journal-title":"Nat. Prod. Chem. Res."},{"issue":"23","key":"10.1016\/j.jconrel.2026.115070_bb1005","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.3c01877","article-title":"A liquid chromatography high-resolution tandem mass spectrometry method to quantify QS-21 adjuvant and its degradation products in liposomal drug formulations","volume":"8","author":"Abucayon","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2026.115070_bb1010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1677995","article-title":"From bark to bench: innovations in QS-21 adjuvant characterization and manufacturing","volume":"16","author":"Talukdar","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115070_bb1015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0169-409X(98)00013-1","article-title":"ISCOMs and other saponin based adjuvants","volume":"32","author":"Barr","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115070_bb1020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.addr.2004.09.006","article-title":"ISCOMATRIX\u00ae adjuvant for antigen delivery","volume":"57","author":"Pearse","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb1025","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2189885","article-title":"The Matrix-M\u2122 adjuvant: a critical component of vaccines for the 21(st) century","volume":"19","author":"Stertman","year":"2023","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2026.115070_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118223","article-title":"QS-21: Structural insights, immunological mechanisms, and prospects for rational design of safer vaccine adjuvants","volume":"301","author":"Hu","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115070_bb1035","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13324","article-title":"Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation","volume":"7","author":"den Brok","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115070_bb1040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02874","article-title":"Adjuvants enhancing cross-presentation by dendritic cells: the key to more effective vaccines?","volume":"9","author":"Ho","year":"2018","journal-title":"Front. Immunol."},{"issue":"66","key":"10.1016\/j.jconrel.2026.115070_bb1045","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf1152","article-title":"A particulate saponin\/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity","volume":"6","author":"Silva","year":"2021","journal-title":"Sci. Immunol."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115070_bb1050","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgae529","article-title":"Modulation of antigen delivery and lymph node activation in nonhuman primates by saponin adjuvant saponin\/monophosphoryl lipid A nanoparticle","volume":"3","author":"Yousefpour","year":"2024","journal-title":"PNAS Nexus"},{"issue":"32","key":"10.1016\/j.jconrel.2026.115070_bb1055","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn7187","article-title":"Saponin nanoparticle adjuvants incorporating Toll-like receptor agonists drive distinct immune signatures and potent vaccine responses","volume":"10","author":"Ou","year":"2024","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115070_bb1060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3390\/vaccines14020159","article-title":"Advances in nanoparticles as vaccine adjuvants","volume":"14","author":"Ahmadivand","year":"2026","journal-title":"Vaccines"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115070_bb1065","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1016\/j.apsb.2024.09.012","article-title":"Next-generation aluminum adjuvants: immunomodulatory layered double hydroxide NanoAlum reengineered from first-line drugs","volume":"14","author":"Su","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115070_bb1070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125168","article-title":"A respiratory mucosal vaccine based on chitosan\/aluminum adjuvant induces both mucosal and systemic immune responses","volume":"670","author":"Chen","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115070_bb1075","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.14202\/vetworld.2021.1689-1694","article-title":"Correlation between antibody response against porcine epidemic diarrhea virus in sows and their offspring under field conditions","volume":"14","author":"Boonsoongnern","year":"2021","journal-title":"Vet. World"},{"key":"10.1016\/j.jconrel.2026.115070_bb1080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.vetmic.2016.11.002","article-title":"Quantifying the effect of lactogenic antibody on porcine epidemic diarrhea virus infection in neonatal piglets","volume":"197","author":"Poonsuk","year":"2016","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115070_bb1085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.virusres.2016.06.002","article-title":"Characterization of anti-porcine epidemic diarrhea virus neutralizing activity in mammary secretions","volume":"226","author":"Song","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.jconrel.2026.115070_bb1090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00727","article-title":"Stage of Gestation at Porcine Epidemic Diarrhea Virus Infection of Pregnant Swine Impacts Maternal Immunity and Lactogenic Immune Protection of Neonatal Suckling Piglets","volume":"10","author":"Langel","year":"2019","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115070_bb1095","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1093\/jn\/131.12.3259","article-title":"Development of intestinal immunoglobulin absorption and enzyme activities in neonatal pigs is diet dependent","volume":"131","author":"Jensen","year":"2001","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb1100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/2049-1891-3-42","article-title":"Influence of birth order, birth weight, colostrum and serum immunoglobulin G on neonatal piglet survival","volume":"3","author":"Cabrera","year":"2012","journal-title":"J Anim Sci Biotechnol"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb1105","doi-asserted-by":"crossref","DOI":"10.1111\/asj.13618","article-title":"Composition and physiological functions of the porcine colostrum","volume":"92","author":"Inoue","year":"2021","journal-title":"Anim. Sci. J."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb1110","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1038\/s41598-023-35277-3","article-title":"The impact of birth weight, birth order, birth asphyxia, and colostrum intake per se on growth and immunity of the suckling piglets","volume":"13","author":"Vodolazska","year":"2023","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115070_bb1115","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00705-025-06459-3","article-title":"Expression of porcine-derived IgA against PEDV and use of Alg-CS gel to protect the IgA from degradation in simulated gastric fluid","volume":"170","author":"Zhang","year":"2025","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb1120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12985-018-1042-3","article-title":"Neutralizing antibodies against porcine epidemic diarrhea virus block virus attachment and internalization","volume":"15","author":"Gong","year":"2018","journal-title":"Virol. J."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115070_bb1125","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms13092199","article-title":"Neutralizing antibodies vs. viruses: interacting mechanisms and escape tactics","volume":"13","author":"Lu","year":"2025","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115070_bb1130","article-title":"IgA: structure, function, and developability","volume":"8","author":"de Sousa-Pereira","year":"2019","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.jconrel.2026.115070_bb1135","article-title":"A single-dose intramuscular nanoparticle vaccine with or without prior intrauterine priming triggers specific uterine and colostral mucosal antibodies and systemic immunity in gilts but not passive protection for suckling piglets","volume":"9","author":"Choudhary","year":"2022","journal-title":"Front. Veterin. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115070_bb1140","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.05233-22","article-title":"Correlation between the IgG\/IgA antibody response against PEDV structural protein and virus neutralization","volume":"11","author":"Song","year":"2023","journal-title":"Microbiol. Spectrum"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb1145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40813-024-00382-w","article-title":"Serum IgA antibody level against porcine epidemic diarrhea virus is a potential pre-evaluation indicator of immunization effects in sows during parturition under field conditions","volume":"10","author":"Hu","year":"2024","journal-title":"Porcine Health Manage."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115070_bb1150","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus Peyer's-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115070_bb1155","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4110\/in.2012.12.5.165","article-title":"Mucosal immune system and m cell-targeting strategies for oral mucosal vaccination","volume":"12","author":"Kim","year":"2012","journal-title":"Immune Netw."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb1160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4049\/jimmunol.1601775","article-title":"Inducing mucosal IgA: a challenge for vaccine adjuvants and delivery systems","volume":"199","author":"Boyaka","year":"2017","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115070_bb1165","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/alr.21944","article-title":"Intranasal distribution and clearance of thermoreversible gel in an animal model","volume":"7","author":"Choi","year":"2017","journal-title":"Int. Forum Allergy Rhinol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb1170","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41541-025-01277-9","article-title":"Aerosol and intranasal delivery of monoclonal antibodies to prevent transmission in pig influenza infection models","volume":"10","author":"Hatton","year":"2025","journal-title":"Npj Vaccines"},{"key":"10.1016\/j.jconrel.2026.115070_bb1175","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.biomaterials.2015.02.010","article-title":"Chitosan-catechol: A polymer with long-lasting mucoadhesive properties","volume":"52","author":"Kim","year":"2015","journal-title":"Biomaterials"},{"issue":"17","key":"10.1016\/j.jconrel.2026.115070_bb1180","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1091\/mbc.e09-04-0320","article-title":"ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton","volume":"20","author":"Van Itallie","year":"2009","journal-title":"Mol. Biol. Cell"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115070_bb1185","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.immuni.2006.01.005","article-title":"Dendritic cells rapidly recruited into epithelial tissues via CCR6\/CCL20 are responsible for CD8+ T cell crosspriming in vivo","volume":"24","author":"Le Borgne","year":"2006","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115070_bb1190","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3109\/00016489.2011.576429","article-title":"A single nasal dose of CCL20 chemokine induces dendritic cell recruitment and enhances nontypable Haemophilus influenzae-specific immune responses in the nasal mucosa","volume":"131","author":"Kodama","year":"2011","journal-title":"Acta Otolaryngol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115070_bb1195","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115070_bb1200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/vaccines14020151","article-title":"A Novel Inactivated Vaccine Based on an Emerging PEDV GIIc Variant Provides Cross-Protection Against Heterologous GII Strains","volume":"14","author":"Xu","year":"2026","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115070_bb1205","doi-asserted-by":"crossref","DOI":"10.3390\/v17020264","article-title":"Epidemiological study and genetic diversity assessment of porcine epidemic diarrhea virus (PEDV) in Yunnan Province, China","volume":"17","author":"Zhu","year":"2025","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb1210","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1186\/s12917-025-04873-y","article-title":"Evolutionary dynamics and antigenic diversity of porcine epidemic diarrhea virus (PEDV) in China: phylogenetic and recombination analyses based on large-scale S gene sequences","volume":"21","author":"Fu","year":"2025","journal-title":"BMC Vet. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb1215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01652176.2025.2509506","article-title":"Neutralizing antibody levels as a key factor in determining the immunogenic efficacy of the novel PEDV alpha coronavirus vaccine","volume":"45","author":"Hu","year":"2025","journal-title":"Vet. Q."},{"key":"10.1016\/j.jconrel.2026.115070_bb1220","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2020.108917","article-title":"Neutralizing monoclonal antibody fails to recognize porcine epidemic diarrhea virus with two regions deleted in spike protein","volume":"251","author":"Liu","year":"2020","journal-title":"Vet. Microbiol."},{"issue":"17","key":"10.1016\/j.jconrel.2026.115070_bb1225","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S1359-6446(05)03536-1","article-title":"Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting","volume":"10","author":"Brayden","year":"2005","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb1230","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejpb.2009.04.009","article-title":"Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination","volume":"73","author":"Fievez","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2026.115070_bb1235","doi-asserted-by":"crossref","DOI":"10.1155\/tbed\/2014296","article-title":"Next-generation vaccines for co-circulating pedv and tgev: integrating nucleic acid platforms, mucosal delivery, and AI-driven antigen design","volume":"2025","author":"Hu","year":"2025","journal-title":"Transbound. Emerg. Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115070_bb1240","doi-asserted-by":"crossref","DOI":"10.1155\/tbed\/3811264","article-title":"Emergence of a Highly Virulent Porcine Epidemic Diarrhea Virus (PEDV) G2c Subtype in China: Isolation, Genetic and Pathogenic Characterization, and Cross-Neutralizing Antibody Response","volume":"2026","author":"Li","year":"2026","journal-title":"Transbound. Emerg. Dis."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:52:08Z","timestamp":1793893928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926004736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":240,"alternative-id":["S0168365926004736"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115070","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering next-generation nanovaccines for maternal immunization and piglet protection against porcine epidemic diarrhea virus","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115070"}}